上海泽涵 生物医药科技有限公司 公司信息
公司名称:
上海泽涵 生物医药科技有限公司
电话:
021-021-61350663
电子邮件:
sales@zehanbiopharma.com
国籍:
中国
网址:
http://www.zehanbiopharma.com
产品总数:
991
3
4
5
6
7
8
9
10
公司提供产品列表
ODM203
ODM203
1430723-35-5
blu667
BLU-667(拉西替尼)
2097132-94-8
TAS-120
FGFR抑制剂(FGFR-IN-1)
1448169-71-8
ETC-1002
贝派地酸
738606-46-7
LOXO-195
LOXO-195
2097002-61-2
Derazantinib (ARQ 087)
德拉赞替尼
1234356-69-4
AZD0364
CS-2696
2097416-76-5
ML204
4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE
5465-86-1
UNC0379
UNC0379
1620401-82-2
N6-cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-9H-purine-2,6-diamine
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺
1246529-32-7
U-104
U-104
178606-66-1
3-Cyano-7-ethoxycoumarin
3-氰基-7-乙氧基香豆素
117620-77-6
3-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile
PF-06447475
1527473-33-1
JH-II-127
JH-II-127
1700693-08-8
MSX-122
MSX 122
897657-95-3
NIBR189
NIBR189
1599432-08-2
Isoxazole 9 (ISX-9)
ISX 9
832115-62-5
SGC707
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
1687736-54-4
XY1
N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
1624117-53-8
Rogaratinib
罗加替尼
1443530-05-9
AT9283
AT9283
896466-04-9
HS1371
HS1371
2158197-70-5
ZL0420
化合物ZL0420
2229039-45-4
PQR309 Bimiralisib
PI3K/MTOR抑制剂
1225037-39-7
IITZ-01
IITZ-01
1807988-47-1
GPR39-C3
CS-2374
1621175-65-2
PMPA(NAALADaseinhibitor)
2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID
173039-10-6
E6005
E6005
947620-48-6
C188-9
432001-19-9
432001-19-9
SF-2523
SF-2523
1174428-47-7
HG-9-91-01
N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲
1456858-58-4
Takinib
1111556-37-6
1111556-37-6
AR7
CS-2649
80306-38-3
5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine
CS-2879
1527473-30-8
GSK
GSK369796
1010411-21-8
Monastrol
CS-2432
254753-54-3
HPI-4
HPI-4
302803-72-1
RS-1
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
312756-74-4
M2I-1
312271-03-7
312271-03-7
Bohemine
BOHEMINE
189232-42-6
2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride
BIX 01294
935693-62-2
TA-01
TA 01
1784751-18-3
PCI 34051
N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺
950762-95-5
BMS-5
BMS-5
1338247-35-0
BMS-3
BMS-3
1338247-30-5
SP2509
无中文名称
1423715-09-6
N/A
4,4'-(pentane-1,5-diylbis(oxy))dibenzimidamide dihydrochloride
50357-35-4
BIIB057 HCl
PRT062607 (HYDROCHLORIDE)
1370261-97-4
FK866
(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide
1198425-96-5
SNX-5422
SNX-5422
908115-27-5
Ponesimod
PONESIMOD
854107-55-4
Eniporide
N-(二氨基亚甲基)-2-甲基-5-(甲基磺酰基)-4-(1H-吡咯-1-基)苯甲酰胺
176644-21-6
N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
GSK2981278
1474110-21-8
B-Raf inhibitor 1 dihydrochloride
B-Raf 抑制剂 1 二盐酸盐
1191385-19-9
MSDC 0160
MSDC-0160
146062-49-9
Ki2 0227
Ki20227
623142-96-1
Nelonicline
Nelonicline
1026134-63-3
Sparsentan (RE-021)
4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-异恶唑基)-2'-(乙氧基甲基)-[1,1'-联苯]-2-磺酰胺
254740-64-2
Retro-2
2,3-DIHYDRO-2-(5-METHYL-2-THIENYL)-3-PHENYL-4(1H)-QUINAZOLINONE
1429192-00-6
Lipofermata
5-溴-5'-苯基-3'H-螺环[吲哚啉-3,2'-[1,3,4]噻二唑]-2-酮
297180-15-5
IWP-O1
IWP-O1
2074607-48-8
V-9302
V-9302
1855871-76-9
DC661
DC661
1872387-43-3
LIT-927
LIT-927游离
2172879-52-4
BAY-8002
2-(2-氯-5-(苯基磺酰基)苯甲酰氨基)苯甲酸
724440-27-1
Larotrectinib (LOXO-101 sulfate)
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐
1223405-08-0
leniolisib(CDZ 173)
LENIOLISIB
1354690-24-6
BAY1125976
CS-2913
1402608-02-9
Capromorelin
卡普瑞林
193273-66-4
FM381
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE
2226521-65-7
CNX2006
CNX2006
1375465-09-0
MK-8353 (SCH900353)
化合物 T12069
1184173-73-6
Rocilinostat (ACY-1215)
ACY1215
1316214-52-4
GSK2982772
GSK2982772
1622848-92-3
APY29
APY29
1216665-49-4
Autophinib
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE
1644443-47-9
SAR-20347
CPDD1211
1450881-55-6
R1487
SY-R1487
449808-64-4
SRT2104 (GSK2245840)
玻玛西林
1093403-33-8
AST487
AST 487
630124-46-8
PD-166285
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐
212391-63-4
Volitinib
沃利替尼
1313725-88-0
BBT594
BBT594
882405-89-2
Entospletinib (GS-9973)
GS-9973
1229208-44-9
URMC-099
URMC-099
1229582-33-5
CP 640186
(R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL
591778-68-6
GSK-3326595
GSK-3326595
1616392-22-3
4SC-202 tosylate
4SC-202(盐的形式)
1186222-89-8
LY2606368 dihydrochloride
CHK1抑制剂
1234015-54-3
KO-947
KO-947
1695533-89-1
BLU-782
BLU-782
2141955-96-4
ARN-3236
3-(2,4-二甲氧基苯基)-4-(3-噻吩基)-1H-吡咯并[2,3-B]吡啶
1613710-01-2
M-2951 (Evobrutinib)
埃沃布鲁替尼
1415823-73-2
Avapritinib (BLU-285)
阿伐普替尼
1703793-34-3
Tomivosertib eFT508
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮
1849590-01-7
MB-07811 ( VK-2809)
MB-07811
852948-13-1
2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]
化合物BET BROMODOMAIN INHIBITOR
1505453-59-7
ALK inhibitor 2
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
761438-38-4
Emedastine
依美斯汀
87233-61-2
SGI-1776
SGI-1776
1025065-69-3
3
4
5
6
7
8
9
10
Copyright 2007© ChemicalBook. All rights reserved.